ALMR
Alamar Biosciences, Inc. Common Stock
NASDAQ: ALMR · HEALTHCARE · MEDICAL DEVICES
$34.30
+7.42% today
Updated 2026-10-28
Market cap
$1.75B
P/E ratio
—
P/S ratio
17.47x
EPS (TTM)
$-1.20
Dividend yield
—
52W range
$17 – $40
Volume
0.6M
Alamar Biosciences, Inc. Common Stock (ALMR) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$34.30
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2024 | 2025 |
|---|---|---|
| Revenue | $0.0B | $0.1B |
| EPS | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -49.40%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.